Table of Contents Global RNA Based Therapeutics Market by Manufacturers, Regions, Type and Application, Forecast to 2023 1 Market Overview 1.1 RNA Based Therapeutics Introduction 1.2 Market Analysis by Type 1.2.1 Microarrays 1.2.2 Labeling 1.2.3 Purification 1.2.4 Linear amplification 1.2.5 ????qRT-PCR 1.2.9 ????RNA Interference (RNAi) technologies 1.2.10 ????RNA antisense technologies 1.3 Market Analysis by Applications 1.3.1 Cardiovascular 1.3.2 Kidney Diseases 1.3.3 Oncology 1.3.4 Infectious diseases 1.3.5 Metabolic disorders 1.3.7 ????Others 1.4 New Project SWOT Analysis of RNA Based Therapeutics 1.5 Industry News Analysis of RNA Based Therapeutics 2 Industrial Chain Analysis 2.1 Industry Chain Structure of RNA Based Therapeutics 2.2 Raw Material Analysis of RNA Based Therapeutics 2.2.1 Raw Material A Market Analysis 2.2.2 Raw Material B Market Analysis 2.2.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of RNA Based Therapeutics 2.4 Other Costs Analysis of RNA Based Therapeutics 2.5 Manufacturing Cost Structure Analysis of RNA Based Therapeutics 2.6 Manufacturing Process Analysis of RNA Based Therapeutics 2.7 Raw Materials Sources of RNA Based Therapeutics Major Manufacturers in 2017 2.8 Downstream Buyers of RNA Based Therapeutics 3 Global RNA Based Therapeutics Players Profiles and Sales Data 3.1 Quark Pharmaceuticals 3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.1.2 RNA Based Therapeutics Product Category, Application and Specification 3.1.2.1 Microarrays 3.1.2.2 Labeling 3.1.2.3 Purification 3.1.3 Quark Pharmaceuticals RNA Based Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Quark Pharmaceuticals Different Types of RNA Based Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.1.5 Quark Pharmaceuticals RNA Based Therapeutics Volume in Different Applications and Its Application Share 3.2 Alnylam Pharmaceuticals 3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.2.2 RNA Based Therapeutics Product Category, Application and Specification 3.2.2.1 Microarrays 3.2.2.2 Labeling 3.2.2.3 Purification 3.2.3 Alnylam Pharmaceuticals RNA Based Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 Alnylam Pharmaceuticals Different Types of RNA Based Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.2.5 Alnylam Pharmaceuticals RNA Based Therapeutics Volume in Different Applications and Its Application Share 3.3 Dicerna Pharmaceuticals 3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.3.2 RNA Based Therapeutics Product Category, Application and Specification 3.3.2.1 Microarrays 3.3.2.2 Labeling 3.3.2.3 Purification 3.3.3 Dicerna Pharmaceuticals RNA Based Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 Dicerna Pharmaceuticals Different Types of RNA Based Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.3.5 Dicerna Pharmaceuticals RNA Based Therapeutics Volume in Different Applications and Its Application Share 3.4 Tekmira Pharmaceuticals 3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.4.2 RNA Based Therapeutics Product Category, Application and Specification 3.4.2.1 Microarrays 3.4.2.2 Labeling 3.4.2.3 Purification 3.4.3 Tekmira Pharmaceuticals RNA Based Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Tekmira Pharmaceuticals Different Types of RNA Based Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.4.5 Tekmira Pharmaceuticals RNA Based Therapeutics Volume in Different Applications and Its Application Share 3.5 Benitec Biopharma Limited 3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.5.2 RNA Based Therapeutics Product Category, Application and Specification 3.5.2.1 Microarrays 3.5.2.2 Labeling 3.5.2.3 Purification 3.5.3 Benitec Biopharma Limited RNA Based Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Benitec Biopharma Limited Different Types of RNA Based Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.5.5 Benitec Biopharma Limited RNA Based Therapeutics Volume in Different Applications and Its Application Share 3.6 Genzyme Corporation 3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.6.2 RNA Based Therapeutics Product Category, Application and Specification 3.6.2.1 Microarrays 3.6.2.2 Labeling 3.6.2.3 Purification 3.6.3 Genzyme Corporation RNA Based Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Genzyme Corporation Different Types of RNA Based Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.6.5 Genzyme Corporation RNA Based Therapeutics Volume in Different Applications and Its Application Share 3.7 ISIS pharmaceuticals 3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.7.2 RNA Based Therapeutics Product Category, Application and Specification 3.7.2.1 Microarrays 3.7.2.2 Labeling 3.7.2.3 Purification 3.7.3 ISIS pharmaceuticals RNA Based Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 ISIS pharmaceuticals Different Types of RNA Based Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.7.5 ISIS pharmaceuticals RNA Based Therapeutics Volume in Different Applications and Its Application Share 3.8 Silence Therapeutics 3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.8.2 RNA Based Therapeutics Product Category, Application and Specification 3.8.2.1 Microarrays 3.8.2.2 Labeling 3.8.2.3 Purification 3.8.3 Silence Therapeutics RNA Based Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 Silence Therapeutics Different Types of RNA Based Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.8.5 Silence Therapeutics RNA Based Therapeutics Volume in Different Applications and Its Application Share 3.9 Cenix BioScience 3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.9.2 RNA Based Therapeutics Product Category, Application and Specification 3.9.2.1 Microarrays 3.9.2.2 Labeling 3.9.2.3 Purification 3.9.3 Cenix BioScience RNA Based Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 Cenix BioScience Different Types of RNA Based Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.9.5 Cenix BioScience RNA Based Therapeutics Volume in Different Applications and Its Application Share 3.10.2.1 Microarrays 3.10.2.2 Labeling 3.10.2.3 Purification 4 Global RNA Based Therapeutics Market Competition by Manufacturers 4.1 Global RNA Based Therapeutics Sales and Share by Manufacturers (2012-2017) 4.2 Global RNA Based Therapeutics Revenue (Million USD) and Share (%) by Manufacturers (2012-2017) 4.3 Market Concentration Rate 4.3.1 Top 3 RNA Based Therapeutics Manufacturer Market Share 4.3.2 Top 6 RNA Based Therapeutics Manufacturer Market Share 4.4 Market Competition Trend 5 Global RNA Based Therapeutics Market Analysis by Regions 5.1 Global RNA Based Therapeutics Sales, Revenue and Market Share by Regions 5.1.1 Global RNA Based Therapeutics Sales by Regions (2012-2017) 5.1.2 Global RNA Based Therapeutics Revenue by Regions (2012-2017) 5.2 North America RNA Based Therapeutics Sales and Growth Rate (2012-2017) 5.3 Europe RNA Based Therapeutics Sales and Growth Rate (2012-2017) 5.4 Asia-Pacific RNA Based Therapeutics Sales and Growth Rate (2012-2017) 5.5 South America RNA Based Therapeutics Sales and Growth Rate (2012-2017) 5.6 Middle East and Africa RNA Based Therapeutics Sales and Growth Rate (2012-2017) 6 North America RNA Based Therapeutics by Countries 6.1 North America RNA Based Therapeutics Sales, Revenue and Market Share by Countries 6.1.1 North America RNA Based Therapeutics Sales by Countries (2012-2017) 6.1.2 North America RNA Based Therapeutics Revenue by Countries (2012-2017) 6.2 United States RNA Based Therapeutics Sales and Growth Rate (2012-2017) 6.3 Canada RNA Based Therapeutics Sales and Growth Rate (2012-2017) 6.4 Mexico RNA Based Therapeutics Sales and Growth Rate (2012-2017) 7 Europe RNA Based Therapeutics by Countries 7.1 North America RNA Based Therapeutics Sales, Revenue and Market Share by Countries 7.1.1 Europe RNA Based Therapeutics Sales by Countries (2012-2017) 7.1.2 Europe RNA Based Therapeutics Sales by Countries (2012-2017) 7.2 Germany RNA Based Therapeutics Sales and Growth Rate (2012-2017) 7.3 France RNA Based Therapeutics Sales and Growth Rate (2012-2017) 7.4 UK RNA Based Therapeutics Sales and Growth Rate (2012-2017) 7.5 Russia RNA Based Therapeutics Sales and Growth Rate (2012-2017) 7.6 Italy RNA Based Therapeutics Sales and Growth Rate (2012-2017) 8 Asia-Pacific RNA Based Therapeutics by Countries 8.1 Asia-Pacific RNA Based Therapeutics Sales, Revenue and Market Share by Countries 8.1.1 Asia-Pacific RNA Based Therapeutics Sales by Countries (2012-2017) 8.1.2 Asia-Pacific RNA Based Therapeutics Sales by Countries (2012-2017) 8.2 China RNA Based Therapeutics Sales and Growth Rate (2012-2017) 8.3 Japan RNA Based Therapeutics Sales and Growth Rate (2012-2017) 8.4 Korea RNA Based Therapeutics Sales and Growth Rate (2012-2017) 8.5 India RNA Based Therapeutics Sales and Growth Rate (2012-2017) 8.6 RNA Based Therapeutics Sales and Growth Rate (2012-2017) 9 South America RNA Based Therapeutics by Countries 9.1 South America RNA Based Therapeutics Sales, Revenue and Market Share by Countries 9.1.1 South America RNA Based Therapeutics Sales by Countries (2012-2017) 9.1.2 South America RNA Based Therapeutics Sales by Countries (2012-2017) 9.2 Brazil RNA Based Therapeutics Sales and Growth Rate (2012-2017) 9.3 Argentina RNA Based Therapeutics Sales and Growth Rate (2012-2017) 9.4 Columbia RNA Based Therapeutics Sales and Growth Rate (2012-2017) 10 Middle East and Africa RNA Based Therapeutics by Countries 10.1 Middle East and Africa RNA Based Therapeutics Sales, Revenue and Market Share by Countries 10.1.1 Middle East and Africa RNA Based Therapeutics Sales by Countries (2012-2017) 10.1.2 Middle East and Africa RNA Based Therapeutics Sales by Countries (2012-2017) 10.2 RNA Based Therapeutics Sales and Growth Rate (2012-2017) 10.3 UAE RNA Based Therapeutics Sales and Growth Rate (2012-2017) 10.4 Egypt RNA Based Therapeutics Sales and Growth Rate (2012-2017) 10.5 Nigeria RNA Based Therapeutics Sales and Growth Rate (2012-2017) 10.6 South Africa RNA Based Therapeutics Sales and Growth Rate (2012-2017) 11 Global RNA Based Therapeutics Market Segment by Type 11.1 Global RNA Based Therapeutics Sales, Revenue and Market Share by Type (2012-2017) 11.1.1 Global RNA Based Therapeutics Sales and Market Share by Type (2012-2017) 11.1.2 Global RNA Based Therapeutics Revenue and Market Share by Type (2012-2017) 11.2 Microarrays Sales Growth Rate and Price 11.2.1 Global Microarrays Sales Growth Rate (2012-2017) 11.2.2 Global Microarrays Price (2012-2017) 11.3 Labeling Sales Growth Rate and Price 11.3.1 Global Labeling Sales Growth Rate (2012-2017) 11.3.2 Global Labeling Price (2012-2017) 11.4 Purification Sales Growth Rate and Price 11.4.1 Global Purification Sales Growth Rate (2012-2017) 11.4.2 Global Purification Price (2012-2017) 11.5 Linear amplification Sales Growth Rate and Price 11.5.1 Global Linear amplification Sales Growth Rate (2012-2017) 11.5.2 Global Linear amplification Price (2012-2017) 11.6 qRT-PCR Sales Growth Rate and Price 11.6.1 Global qRT-PCR Sales Growth Rate (2012-2017) 11.6.2 Global qRT-PCR Price (2012-2017) 12 Global RNA Based Therapeutics by Application 12.1 Global RNA Based Therapeutics Sales Market Share by Application (2012-2017) 12.2 Cardiovascular Sales Growth Rate (2012-2017) 12.3 Kidney Diseases Sales Growth Rate (2012-2017) 12.4 Oncology Sales Growth Rate (2012-2017) 12.5 Infectious diseases Sales Growth Rate (2012-2017) 12.6 Metabolic disorders Sales Growth Rate (2012-2017) 13 Global RNA Based Therapeutics Market Forecast (2018-2023) 13.1 Global RNA Based Therapeutics Sales Volume, Revenue and Price Forecast (2018-2023) 13.1.1 Global RNA Based Therapeutics Sales Volume and Growth Rate Forecast (2018-2023) 13.1.2 Global RNA Based Therapeutics Revenue and Growth Rate Forecast (2018-2023) 13.1.3 Global RNA Based Therapeutics Price and Trend Forecast (2018-2023) 13.2 Global RNA Based Therapeutics Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.1 Global RNA Based Therapeutics Sales Volume and Growth Rate Forecast by Regions (2018-2023) 13.2.2 Global RNA Based Therapeutics Revenue and Growth Rate Forecast by Regions (2018-2023) 13.2.3 Global RNA Based Therapeutics market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including RNA Based Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 13.2.4 North America (United States, Canada and Mexico) RNA Based Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 13.2.5 Europe (Germany, France, UK, Russia and Italy) RNA Based Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 13.2.6 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) RNA Based Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 13.2.7 South America (Brazil, Argentina, Columbia) RNA Based Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 13.2.8 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) RNA Based Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 13.3 Global RNA Based Therapeutics Sales Volume, Revenue and Price Forecast by Type (2018-2023) 13.3.1 Global RNA Based Therapeutics Sales Forecast by Type (2018-2023) 13.3.2 Global RNA Based Therapeutics Revenue Forecast by Type (2018-2023) 13.3.3 Global RNA Based Therapeutics Price Forecast by Type (2018-2023) 13.4 Global RNA Based Therapeutics Sales Volume Forecast by Application (2018-2023) 13.4.1 Global RNA Based Therapeutics Sales Forecast by Application (2018-2023) 13.4.2 Global RNA Based Therapeutics Market Share Forecast by Application (2018-2023) 14 Sales Channel, Distributors, Traders and Dealers 14.1 Sales Channel 14.1.1 Direct Marketing 14.1.2 Indirect Marketing 14.1.3 Marketing Channel Future Trend 14.2 Distributors, Traders and Dealers 15 Research Findings and Conclusion 16 Appendix 16.1 Methodology/Research Approach 16.2 Analyst Introduction 16.3 Data Source

List of Tables and Figures Figure RNA Based Therapeutics Picture Table Product Specifications of RNA Based Therapeutics Figure Global Sales Market Share of RNA Based Therapeutics by Types in 2017 Table RNA Based Therapeutics Types for Major Manufacturers Figure Microarrays Picture Figure Labeling Picture Figure Purification Picture Figure Linear amplification Picture Figure qRT-PCR Picture Figure RNA Based Therapeutics Sales Market Share by Applications in 2017 Figure Cardiovascular Picture Figure Kidney Diseases Picture Figure Oncology Picture Figure Infectious diseases Picture Figure Metabolic disorders Picture Figure New Project SWOT Analysis of RNA Based Therapeutics Table Industry News List of RNA Based Therapeutics Figure Industry Chain Structure of RNA Based Therapeutics Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of RNA Based Therapeutics in 2017 Figure Manufacturing Process Analysis of RNA Based Therapeutics Table Raw Materials Sources of RNA Based Therapeutics Major Manufacturers in 2017 Table Major Buyers of RNA Based Therapeutics Table Quark Pharmaceuticals Basic Information List Table Quark Pharmaceuticals RNA Based Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Quark Pharmaceuticals RNA Based Therapeutics Sales Growth Rate (2012-2017) Figure Quark Pharmaceuticals RNA Based Therapeutics Sales Global Market Share (%) (2012-2017) Figure Quark Pharmaceuticals RNA Based Therapeutics Revenue Global Market Share (%) (2012-2017) Table Microarrays Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Labeling Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Purification Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Quark Pharmaceuticals RNA Based Therapeutics Volume in Cardiovascular and Its Application Share Table Quark Pharmaceuticals RNA Based Therapeutics Volume in Kidney Diseases and Its Application Share Table Quark Pharmaceuticals RNA Based Therapeutics Volume in Oncology and Its Application Share Table Alnylam Pharmaceuticals Basic Information List Table Alnylam Pharmaceuticals RNA Based Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Alnylam Pharmaceuticals RNA Based Therapeutics Sales Growth Rate (2012-2017) Figure Alnylam Pharmaceuticals RNA Based Therapeutics Sales Global Market Share (%) (2012-2017) Figure Alnylam Pharmaceuticals RNA Based Therapeutics Revenue Global Market Share (%) (2012-2017) Table Microarrays Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Labeling Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Purification Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Alnylam Pharmaceuticals RNA Based Therapeutics Volume in Cardiovascular and Its Application Share Table Alnylam Pharmaceuticals RNA Based Therapeutics Volume in Kidney Diseases and Its Application Share Table Alnylam Pharmaceuticals RNA Based Therapeutics Volume in Oncology and Its Application Share Table Dicerna Pharmaceuticals Basic Information List Table Dicerna Pharmaceuticals RNA Based Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Dicerna Pharmaceuticals RNA Based Therapeutics Sales Growth Rate (2012-2017) Figure Dicerna Pharmaceuticals RNA Based Therapeutics Sales Global Market Share (%) (2012-2017) Figure Dicerna Pharmaceuticals RNA Based Therapeutics Revenue Global Market Share (%) (2012-2017) Table Microarrays Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Labeling Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Purification Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dicerna Pharmaceuticals RNA Based Therapeutics Volume in Cardiovascular and Its Application Share Table Dicerna Pharmaceuticals RNA Based Therapeutics Volume in Kidney Diseases and Its Application Share Table Dicerna Pharmaceuticals RNA Based Therapeutics Volume in Oncology and Its Application Share Table Tekmira Pharmaceuticals Basic Information List Table Tekmira Pharmaceuticals RNA Based Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Tekmira Pharmaceuticals RNA Based Therapeutics Sales Growth Rate (2012-2017) Figure Tekmira Pharmaceuticals RNA Based Therapeutics Sales Global Market Share (%) (2012-2017) Figure Tekmira Pharmaceuticals RNA Based Therapeutics Revenue Global Market Share (%) (2012-2017) Table Microarrays Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Labeling Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Purification Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Tekmira Pharmaceuticals RNA Based Therapeutics Volume in Cardiovascular and Its Application Share Table Tekmira Pharmaceuticals RNA Based Therapeutics Volume in Kidney Diseases and Its Application Share Table Tekmira Pharmaceuticals RNA Based Therapeutics Volume in Oncology and Its Application Share Table Benitec Biopharma Limited Basic Information List Table Benitec Biopharma Limited RNA Based Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Benitec Biopharma Limited RNA Based Therapeutics Sales Growth Rate (2012-2017) Figure Benitec Biopharma Limited RNA Based Therapeutics Sales Global Market Share (%) (2012-2017) Figure Benitec Biopharma Limited RNA Based Therapeutics Revenue Global Market Share (%) (2012-2017) Table Microarrays Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Labeling Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Purification Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Benitec Biopharma Limited RNA Based Therapeutics Volume in Cardiovascular and Its Application Share Table Benitec Biopharma Limited RNA Based Therapeutics Volume in Kidney Diseases and Its Application Share Table Benitec Biopharma Limited RNA Based Therapeutics Volume in Oncology and Its Application Share Table Genzyme Corporation Basic Information List Table Genzyme Corporation RNA Based Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Genzyme Corporation RNA Based Therapeutics Sales Growth Rate (2012-2017) Figure Genzyme Corporation RNA Based Therapeutics Sales Global Market Share (%) (2012-2017) Figure Genzyme Corporation RNA Based Therapeutics Revenue Global Market Share (%) (2012-2017) Table Microarrays Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Labeling Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Purification Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Genzyme Corporation RNA Based Therapeutics Volume in Cardiovascular and Its Application Share Table Genzyme Corporation RNA Based Therapeutics Volume in Kidney Diseases and Its Application Share Table Genzyme Corporation RNA Based Therapeutics Volume in Oncology and Its Application Share Table ISIS pharmaceuticals Basic Information List Table ISIS pharmaceuticals RNA Based Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure ISIS pharmaceuticals RNA Based Therapeutics Sales Growth Rate (2012-2017) Figure ISIS pharmaceuticals RNA Based Therapeutics Sales Global Market Share (%) (2012-2017) Figure ISIS pharmaceuticals RNA Based Therapeutics Revenue Global Market Share (%) (2012-2017) Table Microarrays Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Labeling Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Purification Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table ISIS pharmaceuticals RNA Based Therapeutics Volume in Cardiovascular and Its Application Share Table ISIS pharmaceuticals RNA Based Therapeutics Volume in Kidney Diseases and Its Application Share Table ISIS pharmaceuticals RNA Based Therapeutics Volume in Oncology and Its Application Share Table Silence Therapeutics Basic Information List Table Silence Therapeutics RNA Based Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Silence Therapeutics RNA Based Therapeutics Sales Growth Rate (2012-2017) Figure Silence Therapeutics RNA Based Therapeutics Sales Global Market Share (%) (2012-2017) Figure Silence Therapeutics RNA Based Therapeutics Revenue Global Market Share (%) (2012-2017) Table Microarrays Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Labeling Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Purification Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Silence Therapeutics RNA Based Therapeutics Volume in Cardiovascular and Its Application Share Table Silence Therapeutics RNA Based Therapeutics Volume in Kidney Diseases and Its Application Share Table Silence Therapeutics RNA Based Therapeutics Volume in Oncology and Its Application Share Table Cenix BioScience Basic Information List Table Cenix BioScience RNA Based Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Cenix BioScience RNA Based Therapeutics Sales Growth Rate (2012-2017) Figure Cenix BioScience RNA Based Therapeutics Sales Global Market Share (%) (2012-2017) Figure Cenix BioScience RNA Based Therapeutics Revenue Global Market Share (%) (2012-2017) Table Microarrays Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Labeling Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Purification Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Cenix BioScience RNA Based Therapeutics Volume in Cardiovascular and Its Application Share Table Cenix BioScience RNA Based Therapeutics Volume in Kidney Diseases and Its Application Share Table Cenix BioScience RNA Based Therapeutics Volume in Oncology and Its Application Share Table Basic Information List Table RNA Based Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure RNA Based Therapeutics Sales Growth Rate (2012-2017) Figure RNA Based Therapeutics Sales Global Market Share (%) (2012-2017) Figure RNA Based Therapeutics Revenue Global Market Share (%) (2012-2017) Table Microarrays Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Labeling Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Purification Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table RNA Based Therapeutics Volume in Cardiovascular and Its Application Share Table RNA Based Therapeutics Volume in Kidney Diseases and Its Application Share Table RNA Based Therapeutics Volume in Oncology and Its Application Share Table Global RNA Based Therapeutics Sales by Manufacturer (2016-2017) Figure Global RNA Based Therapeutics Sales Market Share by Manufacturer in 2016 Figure Global RNA Based Therapeutics Sales Market Share by Manufacturer in 2017 Table Global RNA Based Therapeutics Revenue by Manufacturer (2016-2017) Figure Global RNA Based Therapeutics Revenue Market Share by Manufacturer in 2016 Figure Global RNA Based Therapeutics Revenue Market Share by Manufacturer in 2017 Figure Top 3 RNA Based Therapeutics Manufacturer (Revenue) Market Share in 2017 Figure Top 6 RNA Based Therapeutics Manufacturer (Revenue) Market Share in 2017 Figure Global RNA Based Therapeutics Sales and Growth Rate (2012-2017) Figure Global RNA Based Therapeutics Revenue and Growth Rate (2012-2017) Table Global RNA Based Therapeutics Sales by Regions (2012-2017) Table Global RNA Based Therapeutics Sales Market Share by Regions (2012-2017) Table Global RNA Based Therapeutics Revenue by Regions (2012-2017) Table Global RNA Based Therapeutics Revenue Market Share by Regions in 2012 Table Global RNA Based Therapeutics Revenue Market Share by Regions in 2017 Figure North America RNA Based Therapeutics Sales and Growth Rate (2012-2017) Figure Europe RNA Based Therapeutics Sales and Growth Rate (2012-2017) Figure Asia-Pacific RNA Based Therapeutics Sales and Growth Rate (2012-2017) Figure South America RNA Based Therapeutics Sales and Growth Rate (2012-2017) Figure Middle East and Africa RNA Based Therapeutics Sales and Growth Rate (2012-2017) Figure North America RNA Based Therapeutics Revenue and Growth Rate (2012-2017) Table North America RNA Based Therapeutics Sales by Countries (2012-2017) Table North America RNA Based Therapeutics Sales Market Share by Countries (2012-2017) Figure North America RNA Based Therapeutics Sales Market Share by Countries in 2012 Figure North America RNA Based Therapeutics Sales Market Share by Countries in 2017 Table North America RNA Based Therapeutics Revenue by Countries (2012-2017) Table North America RNA Based Therapeutics Revenue Market Share by Countries (2012-2017) Figure North America RNA Based Therapeutics Revenue Market Share by Countries in 2012 Figure North America RNA Based Therapeutics Revenue Market Share by Countries in 2017 Figure United States RNA Based Therapeutics Sales and Growth Rate (2012-2017) Figure Canada RNA Based Therapeutics Sales and Growth Rate (2012-2017) Figure Mexico RNA Based Therapeutics Sales and Growth Rate (2012-2017) Figure Europe RNA Based Therapeutics Revenue and Growth Rate (2012-2017) Table Europe RNA Based Therapeutics Sales by Countries (2012-2017) Table Europe RNA Based Therapeutics Sales Market Share by Countries (2012-2017) Table Europe RNA Based Therapeutics Revenue by Countries (2012-2017) Table Europe RNA Based Therapeutics Revenue Market Share by Countries in 2012 Table Europe RNA Based Therapeutics Revenue Market Share by Countries in 2017 Figure Germany RNA Based Therapeutics Sales and Growth Rate (2012-2017) Figure UK RNA Based Therapeutics Sales and Growth Rate (2012-2017) Figure France RNA Based Therapeutics Sales and Growth Rate (2012-2017) Figure Russia RNA Based Therapeutics Sales and Growth Rate (2012-2017) Figure Italy RNA Based Therapeutics Sales and Growth Rate (2012-2017) Figure Asia-Pacific RNA Based Therapeutics Revenue and Growth Rate (2012-2017) Table Asia-Pacific RNA Based Therapeutics Sales by Countries (2012-2017) Table Asia-Pacific RNA Based Therapeutics Sales Market Share by Countries (2012-2017) Table Asia-Pacific RNA Based Therapeutics Sales Market Share by Countries (2012-2017) Table Asia-Pacific RNA Based Therapeutics Revenue by Countries (2012-2017) Table Asia-Pacific RNA Based Therapeutics Revenue Market Share by Countries (2012-2017) Figure China RNA Based Therapeutics Sales and Growth Rate (2012-2017) Figure Japan RNA Based Therapeutics Sales and Growth Rate (2012-2017) Figure Korea RNA Based Therapeutics Sales and Growth Rate (2012-2017) Figure India RNA Based Therapeutics Sales and Growth Rate (2012-2017) Figure Southeast Asia RNA Based Therapeutics Sales and Growth Rate (2012-2017) Figure South America RNA Based Therapeutics Revenue and Growth Rate (2012-2017) Table South America RNA Based Therapeutics Sales by Countries (2012-2017) Table South America RNA Based Therapeutics Sales Market Share by Countries (2012-2017) Figure South America RNA Based Therapeutics Sales Market Share by Countries in 2017 Table South America RNA Based Therapeutics Revenue by Countries (2012-2017) Table South America RNA Based Therapeutics Revenue Market Share by Countries (2012-2017) Figure South America RNA Based Therapeutics Revenue Market Share by Countries in 2017 Figure Brazil RNA Based Therapeutics Sales and Growth Rate (2012-2017) Figure Argentina RNA Based Therapeutics Sales and Growth Rate (2012-2017) Figure Columbia RNA Based Therapeutics Sales and Growth Rate (2012-2017) Figure Middle East and Africa RNA Based Therapeutics Revenue and Growth Rate (2012-2017) Table Middle East and Africa RNA Based Therapeutics Sales by Countries (2012-2017) Table Middle East and Africa RNA Based Therapeutics Sales Market Share by Countries (2012-2017) Figure Middle East and Africa RNA Based Therapeutics Sales Market Share by Countries in 2017 Table Middle East and Africa RNA Based Therapeutics Revenue by Countries (2012-2017) Table Middle East and Africa RNA Based Therapeutics Revenue Market Share by Countries (2012-2017) Figure Middle East and Africa RNA Based Therapeutics Revenue Market Share by Countries in 2012 Figure Middle East and Africa RNA Based Therapeutics Revenue Market Share by Countries in 2017 Figure Saudi Arabia RNA Based Therapeutics Sales and Growth Rate (2012-2017) Figure UAE RNA Based Therapeutics Sales and Growth Rate (2012-2017) Figure Egypt RNA Based Therapeutics Sales and Growth Rate (2012-2017) Figure Nigeria RNA Based Therapeutics Sales and Growth Rate (2012-2017) Figure South Africa RNA Based Therapeutics Sales and Growth Rate (2012-2017) Table Global RNA Based Therapeutics Sales by Type (2012-2017) Table Global RNA Based Therapeutics Sales Share by Type (2012-2017) Table Global RNA Based Therapeutics Revenue by Type (2012-2017) Table Global RNA Based Therapeutics Revenue Share by Type (2012-2017) Figure Global Microarrays Sales Growth Rate (2012-2017) Figure Global Microarrays Sales Price (2012-2018) Figure Global Microarrays Sales Growth Rate (2012-2017) Figure Global Labeling Sales Price (2012-2018) Figure Global Purification Sales Growth Rate (2012-2017) Figure Global Purification Sales Price (2012-2018) Figure Global Linear amplification Sales Growth Rate (2012-2017) Figure Global Linear amplification Sales Growth Rate (2012-2018) Figure Global qRT-PCR Sales Growth Rate (2012-2017) Figure Global qRT-PCR Sales Price (2012-2018) Table Global RNA Based Therapeutics Sales by Application (2012-2017) Table Global RNA Based Therapeutics Sales Share by Application (2012-2017) Figure Global Cardiovascular Sales Growth Rate (2012-2017) Figure Global Kidney Diseases Sales Growth Rate (2012-2017) Figure Global Oncology Sales Growth Rate (2012-2019) Figure Global Infectious diseases Sales Growth Rate (2012-2020) Figure Global Metabolic disorders Sales Growth Rate (2012-2021) Figure Global Others Sales Growth Rate (2012-2022) Figure Global RNA Based Therapeutics Sales, Revenue and Growth Rate (2018-2023) Table Global RNA Based Therapeutics Sales Forecast by Regions (2018-2023) Table Global RNA Based Therapeutics Market Share Forecast by Regions (2018-2023) Figure North America Sales RNA Based Therapeutics Market Forecast (2018-2023) Figure Europe Sales RNA Based Therapeutics Market Forecast (2018-2023) Figure Asia-Pacific Sales RNA Based Therapeutics Market Forecast (2018-2023) Figure South America Sales RNA Based Therapeutics Market Forecast (2018-2023) Figure Middle East and Africa Sales RNA Based Therapeutics Market Forecast (2018-2023) Table Global RNA Based Therapeutics Sales Forecast by Type (2018-2023) Table Global RNA Based Therapeutics Market Share Forecast by Type (2018-2023) Table Global RNA Based Therapeutics Sales Forecast by Application (2018-2023) Table Global RNA Based Therapeutics Market Share Forecast by Application (2018-2023) Table Distributors/Traders/ Dealers List

Quark Pharmaceuticals Alnylam Pharmaceuticals Dicerna Pharmaceuticals Tekmira Pharmaceuticals Benitec Biopharma Limited Genzyme Corporation ISIS pharmaceuticals Silence Therapeutics Cenix BioScience